Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01729429 · ClinicalTrials.gov registry record · NA

An Intervention Promoting HPV Vaccination in Safety-net Clinics

A NA study, sponsored by University of Texas Southwestern Medical Center.

Completed
Registry status
NA
Development phase
831
Enrollment target

NCT01729429 is a NA study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 831 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01729429, a NA study, has completed, sponsored by University of Texas Southwestern Medical Center.

COMPLETED
Registry status
NA
Development phase
831 participants
Enrollment target

Study Summary

This randomized controlled trial is designed to evaluate whether a behavioral intervention that includes three components: 1) reminder letters and education materials delivered before the clinic visit, 2) telephone recalls after the visit for those who originally decline the vaccine, and 3) telephone reminders for those who miss the 2nd and/or 3rd doses, increases 1 and 3 dose coverage of the human papillomavirus (HPV) vaccine series among adolescent girls attending four Parkland primary care clinics in Dallas county. Hypothesis 1: Investigators expect higher 1 dose HPV vaccine coverage among patients in the Intervention group than those in the General Adolescent Vaccine Brochure group. Hypothesis 2: Investigators expect significantly higher 1 dose HPV vaccine coverage among patients in the Intervention group who initially declined the vaccine than those in the General Adolescent Vaccine Brochure group who initially declined. Hypothesis 3: Investigators expect significantly higher 3 dose HPV vaccine coverage among the Intervention group than those in the General Adolescent Vaccine Brochure group.

Interventions

  • BEHAVIORAL HPV brochure, recall, reminders
  • BEHAVIORAL General Adolescent Vaccine Brochure

Trial Details

FieldValue
Enrollment Target 831 participants
Start Date 2010-05
Est. Completion 2012-11
Phase NA

What the Registry Record Tells You About NCT01729429

The ClinicalTrials.gov registry entry for NCT01729429 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 831 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which HPV brochure, recall, reminders is the first listed.

NCT01729429 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01729429 about?

NCT01729429 is a clinical study titled "An Intervention Promoting HPV Vaccination in Safety-net Clinics". This randomized controlled trial is designed to evaluate whether a behavioral intervention that includes three components: 1) reminder letters and education materials delivered before the clinic visit, 2) telephone recalls after the visit for those who originally decline the vaccine, and 3) telephon...

What is the current status of trial NCT01729429?

This trial is currently completed. It is a NA study. The enrollment target is 831 participants. The study started on 2010-05. Estimated completion is 2012-11.

What interventions are being tested in trial NCT01729429?

The interventions under investigation include: HPV brochure, recall, reminders (BEHAVIORAL), General Adolescent Vaccine Brochure (BEHAVIORAL).

Who is sponsoring clinical trial NCT01729429?

This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.